Delivery Order SPE2DB24D1007-SPE2DB26FB5PW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $55,198.97 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets (90-count packaging). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. The ultimate completion date is September 23, 2025, with the award issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency for 30 tablets of Jardiance 10 mg, with a ceiling value of $10,510.63 and an ultimate completion date of September 15, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90-count bottles of Jardiance 10 mg tablets, valued at $22,225.71. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation and represents a continuation of the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets in a 90-count quantity. This firm fixed-price contract, awarded on July 17, 2025, carries a ceiling value of $9,648.60 and is scheduled for ultimate completion by July 18, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $4,328.80 and an ultimate completion date of August 8, 2025. This award represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,871.96. The order is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order operates under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB26FB5PWDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $17,412.62 for 90 tablets of Jardiance 25 mg by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is set to be completed by October 17, 2025, and represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The company serves as a critical pharmaceutical vendor for the military healthcare supply chain, providing brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order exemplifies the operational scope of AmerisourceBergen's role as a primary pharmaceutical supplier within the federal medical procurement system. As a child contract under the broader SPE2DX indefinite delivery vehicle, this award for the diabetes medication Jardiance reflects the company's ongoing responsibility to supply pharmaceutical products to military and veteran healthcare systems. The non-set-aside, competitively awarded status underscores AmerisourceBergen's capability to meet federal procurement standards through open competition, and the firm fixed-price arrangement provides cost certainty for this specific pharmaceutical delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 10/16/25 |